$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Method for making a microsealed delivery device 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/00
  • A61K-009/26
출원번호 US-0617542 (1975-09-29)
발명자 / 주소
  • Chien Yie W. (Skokie IL) Lambert Howard J. (Deerfield IL)
출원인 / 주소
  • G. D. Searle & Co. (Chicago IL 02)
인용정보 피인용 횟수 : 107  인용 특허 : 1

초록

The present invention is concerned with a pharmaceutical delivery device comprising a biologically acceptable silicone polymer matrix having microsealed compartments of 10-200 microns throughout, wherein the microsealed compartments contain a pharmaceutical in a hydrophilic solvent system. The biolo

대표청구항

A METHOD FOR CONSTRUCTING A BIOLOGICALLY ACCEPTABLE SILICONE POLYMER MATRIX ADAPTED FOR PLACEMENT IN SILICONE POLYMER OR ETHYLENE/VINYLACETATE COPOLYMER TUBING HAVING 10-200 MICRON MICROSEALED COMPARTMENTS DISTRIBUTED THROUGHOUT, SAID MICROSEALED COMPARTMENTS CONTAINING A PHARMACEUTICAL IN A HYDROPH

이 특허에 인용된 특허 (1)

  1. Chien Yie W. (Skokie IL) Lambert Howard J. (Deerfield IL), Microsealed pharmaceutical delivery device.

이 특허를 인용한 특허 (107)

  1. Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use.
  2. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  3. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  4. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  5. Zerangue,Noa; Jandeleit,Bernd; Li,Yunxiao; Gallop,Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  6. Gallop, Mark A.; Xu, Feng; Phan, Thu; Dilip, Usha; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  7. Gallop, Mark A.; Xu, Feng; Phan, Thu; Dilip, Usha; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  8. Gallop, Mark A.; Yao, Fenmei; Ludwikow, Maria J.; Phan, Thu; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  9. Gallop, Mark A.; Yao, Fenmei; Ludwikow, Maria J.; Phan, Thu; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  10. Gallop,Mark A.; Yao,Fenmei; Ludwikow,Maria J.; Phan,Thu; Peng,Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  11. Gallop,Mark A.; Yao,Fenmei; Ludwikow,Maria J.; Phan,Thu; Peng,Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  12. Gallop,Mark A., Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use.
  13. Gallop, Mark; Cundy, Kenneth C.; Scheuerman, Randall A.; Barrett, Ronald W.; Zerangue, Noa, Amino acid conjugates providing for sustained systemic concentrations of GABA analogues.
  14. Gallop,Mark; Cundy,Kenneth C.; Scheuerman,Randall A.; Barrett,Ronald W.; Zerangue,Noa, Amino acid conjugates providing for sustained systemic concentrations of GABA analogues.
  15. Schellenberger, Volker; Stemmer, Willem P.; Wang, Chia-Wei; Scholle, Michael D.; Gordon, Nathaniel C.; Crameri, Andreas; Popkov, Mikhail, Biologically active proteins having increased in vivo and/or in vitro stability.
  16. Xiang,Jia Ning; Gallop,Mark A.; Cundy,Kenneth C.; Li,Jianhua; Xu,Feng; Zhou,Cindy X.; Bhat,Laxminarayan, Carbidopa prodrugs and derivatives, and compositions and uses thereof.
  17. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q., Catechol protected levodopa diester prodrugs, compositions, and methods of use.
  18. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q., Catechol protected levodopa diester prodrugs, compositions, and methods of use.
  19. Schellenberger, Volker; Stemmer, Willem P.; Geething, Nathan C.; To, Wayne; Silverman, Joshua; Wang, Chia-wei; Spink, Benjamin, Coagulation factor IX compositions and methods of making and using same.
  20. Schellenberger, Volker; Stemmer, Willem P.; Geething, Nathan C.; To, Wayne; Silverman, Joshua; Wang, Chia-wei; Spink, Benjamin, Coagulation factor IX compositions and methods of making and using same.
  21. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Composition for administering an NMDA receptor antagonist to a subject.
  22. Stemmer, Willem P.; Schellenberger, Volker, Compositions comprising modified biologically active polypeptides.
  23. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Compositions for the treatment of CNS-related conditions.
  24. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Compositions for the treatment of CNS-related conditions.
  25. Zimmerman Ronald E. (Danville IN) Burck Philip J. (Indianapolis IN) Dunn Richard L. (Birmingham AL), Contraceptive device.
  26. Runkel, Richard A.; Lee, Jung-Chung, Controlled release subcutaneous implant.
  27. Cyprien Guy (L\Hay les Roses FRX) Fisch Alain (Paris FRX) Haggiage Johnny (Lyon FRX) Porte Hugues (Caluire FRX) Prazuck Thierry (Paris FRX) Torres Ghislaine (Lyon FRX), Diorganopolysiloxane dosage forms for the controlled release of iodine values.
  28. Gupta Suneel K. ; Guinta Diane R. ; Christopher Carol A. ; Saks Samuel R., Dosage form and method for administering drug.
  29. Kim Benjamin K. (Toms River NJ), Estradiol transdermal delivery system.
  30. Schellenberger, Volker; Silverman, Joshua; Wang, Chia-Wei; Spink, Benjamin; Stemmer, Willem P.; Geething, Nathan; To, Wayne; Cleland, Jeffrey L., Extended recombinant polypeptides and compositions comprising same.
  31. Schellenberger, Volker; Silverman, Joshua; Wang, Chia-wei; Spink, Benjamin; Stemmer, Willem P.; Geething, Nathan; To, Wayne; Cleland, Jeffrey L., Extended recombinant polypeptides and compositions comprising same.
  32. Schellenberger, Volker; Silverman, Joshua; Wang, Chia-wel; Spink, Benjamin; Stemmer, Willem P.; Geething, Nathan C.; To, Wayne; Cleland, Jeffrey L., Extended recombinant polypeptides and compositions comprising same.
  33. Cundy, Kenneth C.; Sastry, Srikonda; Leung, Manshiu; Kadri, Balaji V.; Stach, Paul E., GABA analog prodrug sustained release oral dosage forms.
  34. Cundy, Kenneth C.; Sastry, Srikonda; Leung, Manshiu; Kadri, Balaji V.; Stach, Paul E., GABA analog prodrug sustained release oral dosage forms.
  35. Muldoon, Brendan; Lorimer, Colin; Gilligan, Claire, Intravaginal matrix drug delivery devices.
  36. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q., Levodopa dimethyl-substituted diester prodrugs compositions, and methods of use.
  37. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q., Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use.
  38. Karaborni, Sami; Leung, Manshiu; Mao, Chen; Thalladi, Venkat, Levodopa prodrug mesylate hydrate.
  39. Karaborni, Sami; Leung, Manshiu; Mao, Chen; Thalladi, Venkat R., Levodopa prodrug mesylate hydrate.
  40. Xiang, Jia Ning; Dai, Xuedong; Zhou, Cindy X.; Li, Jianhua; Nguyen, Mark Q., Levodopa prodrug mesylate, compositions thereof, and uses thereof.
  41. Xiang, Jia-Ning; Dai, Xuedong; Zhou, Cindy X.; Li, Jianhua; Nguyen, Mark Q., Levodopa prodrug mesylate, compositions thereof, and uses thereof.
  42. Xiang, Jia-Ning; Dai, Xuedong; Zhou, Cindy X.; Li, Jianhua; Nguyen, Mark Q., Levodopa prodrug mesylate, compositions thereof, and uses thereof.
  43. Xiang, Jia-Ning; Dai, Xuedong; Zhou, Cindy X.; Li, Jianhua; Nguyen, Mark Q., Levodopa prodrug mesylate, compositions thereof, and uses thereof.
  44. Xiang, Jia Ning; Gallop, Mark A.; Zhou, Cindy X.; Nguyen, Mark; Dai, Xuedong; Li, Jianhua; Cundy, Kenneth C.; Jumbe, Nelson L., Levodopa prodrugs, and compositions and uses thereof.
  45. Xiang, Jia-Ning; Gallop, Mark A.; Zhou, Cindy X.; Nguyen, Mark; Dai, Xuedong; Li, Jianhua; Cundy, Kenneth C.; Jumbe, Nelson L., Levodopa prodrugs, and compositions and uses thereof.
  46. Xiang, Jia-Ning; Gallop, Mark A.; Zhou, Cindy X.; Nguyen, Mark; Dai, Xuedong; Li, Jianhua; Cundy, Kenneth C.; Jumbe, Nelson L., Levodopa prodrugs, and compositions and uses thereof.
  47. Xiang,Jia Ning; Gallop,Mark A.; Zhou,Cindy X.; Nguyen,Mark; Dai,Xuedong; Li,Jianhua; Cundy,Kenneth C., Levodopa prodrugs, and compositions and uses thereof.
  48. Xiang,Jia Ning; Gallop,Mark A.; Zhou,Cindy X.; Nguyen,Mark; Dai,Xuedong; Li,Jianhua; Cundy,Kenneth C.; Jumbe,Nelson L., Levodopa prodrugs, and compositions and uses thereof.
  49. Went, Gregory T.; Fultz, Timothy J.; Porter, Seth; Meyerson, Laurence R.; Burkoth, Timothy S., Method and composition for administering an NMDA receptor antagonist to a subject.
  50. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Method for administering an NMDA receptor antagonist to a subject.
  51. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Method for administering an NMDA receptor antagonist to a subject.
  52. Guittard George V. ; Jao Francisco ; Marks Susan M. ; Kidney David J. ; Gumucio Fernando E., Method for the management of incontinence.
  53. Guittard, George V.; Jao, Francisco; Marks, Susan M.; Kidney, David J.; Gumucio, Fernando E., Method for the management of incontinence.
  54. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  55. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  56. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  57. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  58. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  59. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Methods and compositions for the treatment of CNS-related conditions.
  60. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Methods and compositions for the treatment of CNS-related conditions.
  61. Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
  62. Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
  63. Gupta, Suneel K.; Guinta, Diane R; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
  64. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Hatamkhany, Zahedeh; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Weyers, Richar, Methods and devices for providing prolonged drug therapy.
  65. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Hatamkhany, Zahedeh; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Weyers, Richard G., Methods and devices for providing prolonged drug therapy.
  66. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Weyers, Richard G.; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Hatamkhany, Zah, Methods and devices for providing prolonged drug therapy.
  67. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D; Hatamkhany, Zahedeh; Weyers, Richard G; Gupta, Suneel K.; Guinta, Diane R; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D., Methods and devices for providing prolonged drug therapy.
  68. Yam, Nyomi V.; Reyes, Iran; Davar, Nipun; Ayer, Atul D.; Lee, Julie; Seroff, Sonya; Gupta, Suneel K.; Sathyan, Gayatri, Methods and dosage forms for controlled delivery of paliperidone and risperidone.
  69. Schellenberger, Volker; Stemmer, Willem P.; Wang, Chia-wei; Scholle, Michael D.; Popkov, Mikhail; Gordon, Nathaniel C.; Crameri, Andreas, Methods for production of unstructured recombinant polymers and uses thereof.
  70. Raillard,Stephen P.; Zhou,Cindy X.; Yao,Fenmei; Manthati,Suresh Kumar; Xiang,Jia Ning; Gallop,Mark A., Methods for synthesis of acyloxyalkyl derivatives of GABA analogs.
  71. Raillard,Stephen P.; Zhou,Cindy X.; Yao,Fenmei; Manthati,Suresh Kumar; Xiang,Jia Ning; Gallop,Mark A., Methods for synthesis of acyloxyalkyl derivatives of GABA analogs.
  72. Went, Gregory T.; Fultz, Timothy J.; Meyerson, Laurence R., Methods for the treatment of CNS-related conditions.
  73. Went, Gregory T.; Fultz, Timothy J.; McClure, Natalie, Methods of administering amantadine.
  74. Raillard, Stephen P.; Mann, Adam; Manthati, Suresh K.; Scheuerman, Randall A.; Estrada, Tono; Nguyen, Mark Q.; Zhou, Cindy X, Methods of synthesizing a levodopa ester prodrug.
  75. Zsifkovits Wilhelm (Korneuburg ATX) Grning Burghard (Essen DEX) Kollmeier Hans-Joachim (Essen DEX) Schaefer Dietmar (Essen DEX) Weitemeyer Christian (Essen DEX), Microcapsule and micromatrix bodies and method for their formation.
  76. Chien Yie W. (Skokie IL) Lambert Howard J. (Deerfield IL), Microsealed pharmaceutical delivery device.
  77. Cundy, Kenneth C.; Gallop, Mark A., Orally administered dosage forms of GABA analog prodrugs having reduced toxicity.
  78. Mao, Chen; Pargaonkar, Nikhil; Maurer, Laura E.; Ma, Sarina Grace Harris, Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use.
  79. Aguadisch Louis M. J. (Valbonne FRX) Rankin Frank S. (South Glamorgan GB7), Pharmaceutical delivery device having a siloxane polymer matrix.
  80. Caron Daniele (Valbonne FRX) Shroot Braham (Antibes FRX), Pharmaceutical vehicle for active substances in the form of an anhydrous gel.
  81. Gao,Qingzhi; Gallop,Mark A.; Xiang,Jia Ning, Platinum-containing compounds exhibiting cytostatic activity, synthesis and methods of use.
  82. Cyprien Guy (L\Hay les Roses FRX) Fisch Alain (Paris FRX) Haggiage Johnny (Lyons FRX) Porte Hugues (Caluire FRX) Prazuck Thierry (Paris FRX) Torres Ghislaine (Lyons FRX), Polyaddition silicone elastomer dosage forms for the controlled release of iodine values.
  83. Mathiowitz Edith (Brookline MA) Langer Robert S. (Somerville MA) Warshawsky Abraham (Rehovot MA ILX) Edelman Elazar (Brookline MA), Polymer composite for controlled release or membrane formation.
  84. Totakura Nagabhushanam (North Haven CT) Shalaby Shalaby W. (Anderson SC), Polymeric composition.
  85. Lee Jung-Chung ; Pushpala Shamim ; Lee Charles E., Polymeric microporous film coated subcutaneous implant.
  86. Jenkins, Thomas E., Polysubunit opioid prodrugs resistant to overdose and abuse.
  87. Jenkins, Thomas E., Polysubunit opioid prodrugs resistant to overdose and abuse.
  88. Gallop, Mark A., Prodrugs of gaba analogs, compositions and uses thereof.
  89. Rodstrom, Theron R.; Smith, II, Larry; Tian, Youqin; Marsh, David Allen; Weiner, Alan L.; Bakshi, Shivalik, Punctal plugs and methods of delivering therapeutic agents.
  90. Hudson James L. (Indianapolis IN) Wagner Jack F. (Greenfield IN), Removable drug implant.
  91. Nuwayser Elie S. (Wellesley MA), Sustained release transdermal drug delivery composition.
  92. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  93. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  94. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  95. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  96. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  97. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  98. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  99. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  100. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  101. Nonomura Muneo (Osaka JPX) Suzuki Yasuyuki (Osaka JPX) Yamada Masayuki (Hyogo JPX), Sustained-release preparation and production thereof.
  102. Nangia, Avinash; Verma, Daya D.; Jacob, Jules, Topiramate compositions and methods of enhancing its bioavailability.
  103. Sanvordeker Dilip R. (Elk Grove IL) Cooney James G. (Des Plaines IL) Wester Ronald C. (Glenview IL), Transdermal nitroglycerin pad.
  104. Chien Yie W. (North Brunswick NJ) Tojo Kakuji (Highland Park NJ), Transdermal varapamil delivery device.
  105. Barrett, Ronald W.; Canafax, Daniel M., Treating or preventing restless legs syndrome using prodrugs of GABA analogs.
  106. Barrett, Ronald W., Treating urinary incontinence using prodrugs of GABA analogs.
  107. Schellenberger, Volker; Stemmer, Willem P.; Wang, Chia-wei; Scholle, Michael D.; Popkov, Mikhail; Gordon, Nathaniel C.; Crameri, Andreas, Unstructured recombinant polymers and uses thereof.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로